Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

Inclusion Criteria

• •1. Written informed consent was obtained to participate in the study and HIPAA authorization for release of personal health information. Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
• •2. Age ≥18 years at the time of consent.
• •3. Eastern Cooperative Oncology Group (ECOG) ≤ 2
• •4. Subjects with Multiple Myeloma.